Latest Cash Flow News

Origin Energy’s June 2025 quarterly report reveals a slight dip in LNG revenue due to softer prices, steady production, and robust customer expansion across its retail and international businesses.

Native Mineral Resources Holdings Limited reported significant cash outflows in its June quarter, offset by a recent $10 million share placement aimed at supporting its Blackjack Milling gold project development.

EV Resources has secured a 70% stake in the Los Lirios Antimony Project, unveiling high-grade mineralisation and plans for a pilot plant to accelerate production. Leadership enhancements and portfolio rationalisation underscore its strategic pivot to critical minerals.

NT Minerals Limited reported a net cash outflow of A$84,000 for operating activities in Q2 2025, maintaining a strong funding position with A$1.46 million available to support ongoing exploration.

Native Mineral Resources has poured its first gold at the Blackjack Gold Project in Queensland, marking a pivotal shift from development to production with initial revenue generated.

XPON Technologies reported a strong Q4 FY25 with a 27% revenue jump driven by its Alpha Digital acquisition, while targeting positive EBITDA and cash flow from Q2 FY26.

Everest Metals Corporation Ltd reported a cautious cash flow update for Q2 2025, highlighting ongoing exploration costs and a funding runway of just under two quarters. The company has completed bulk sampling at its Revere Gold Project but faces continued negative operating cash flows.

Red Hill Minerals reported robust royalty revenues and exploration progress in the June 2025 quarter, underpinned by strong iron ore shipments and strategic royalty acquisitions. The company’s solid cash position and advancing drill programs position it well for growth.

NEXION Group Ltd has exited a major transaction, sold its Perth data centre, and relaunched its AI-focused subsidiary, positioning itself for renewed growth and ASX reinstatement.

Knosys Limited sustains a robust $9.8 million Annual Recurring Revenue, extends its ANZ Bank contract, and accelerates AI-driven library technology development with promising early market feedback.

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology candidate, completed FDA IND transfer, and plans to launch phase II trials in 2026. The company also reported a solid cash position and issued loyalty options to shareholders.

Australia United Mining reports steady progress at its Sofala gold project and maintenance at Queensland’s Ropewalk mine, while facing a limited cash runway supported by related party loans and share investments.